Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 2/20 | 0.34 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SCD | O00767 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8579690 | 0.98 | TOP2A (0.35) | TOP2ATOP2BMEN1KMT2ASCD | |
| SCHEMBL9168417 | 0.98 | TOP2A (0.35) | TOP2ATOP2BMEN1KMT2ASCD | |
| SCHEMBL10616840 | 0.98 | TOP2A (0.35) | TOP2ATOP2BMEN1KMT2ASCD | |
| SCHEMBL10617494 | 0.98 | TOP2A (0.35) | TOP2ATOP2BMEN1KMT2ASCD | |
| SCHEMBL9164590 | 0.98 | TOP2A (0.35) | TOP2ATOP2BMEN1KMT2ASCD | |
| SCHEMBL10792536 | 0.98 | TOP2A (0.35) | TOP2ATOP2BMEN1KMT2ASCD | |
| Hydrochloric Acid SCHEMBL11117732 | 0.96 | TOP2A (0.36) | TOP2ATOP2BMEN1KMT2ASCD | |
| Acetic Acid SCHEMBL11165000 | 0.91 | SCD (0.41) | SCD | |
| Diethylamine SCHEMBL10618390 | 0.90 | TOP2A (0.34) | TOP2ATOP2BMEN1KMT2A | |
| SCHEMBL27315899 | 0.90 | SCD (0.33) | TOP2ATOP2BMEN1KMT2ASCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110186299-A1 | Low-Toxicity Biodegradable Corrosion Inhibitors | ARKEMA FRANCE (FR) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110186299-A1 | Low-Toxicity Biodegradable Corrosion Inhibitors | DDT, IDE, DGKI | TOP2A 1505/4885TOP2B 2441/4885MEN1 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.